Southern California Biomedical Council (SoCalBio) is a nonprofit, member-supported trade association that serves the biotech, med tech, IVD and digital health communities in the six counties that comprise the Greater Los Angeles region (Los Angeles, Orange, Ventura, Santa Barbara, Riverside and San Bernardino). SoCalBio’s programs help local firms gain access to capital, potential partners, and other business services. The Council also promotes technology transfer and workforce training, while informing policymakers and the public at-large about the benefits of the region’s bioscience industry. SoCalBio is open to membership by firms and organizations engaged in all aspects of bioscience research, technology development, and commercialization.
ADRx is advancing drug candidates for Alzhiemer’s disease, systemic amyloidosis and ovarian cancer. The ADRx team has developed ADvantage, a novel drug discovery technology platform that leverages our deep understanding of amyloid protein structure, aggregation and function.